Literature DB >> 19514091

Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.

Melissa M Murphy1, Jessica P Simons, Joshua S Hill, Theodore P McDade, Sing Chau Ng, Giles F Whalen, Shimul A Shah, Lynn H Harrison, Jennifer F Tseng.   

Abstract

BACKGROUND: Blacks are affected disproportionately by pancreatic adenocarcinoma and have been linked with poor survival. Surgical resection remains the only potential curative option. If surgical disparities exist, then they may provide insight into outcome discrepancies.
METHODS: Patients with pancreatic adenocarcinoma were identified using the National Cancer Institute's Surveillance, Epidemiology, and End Results data from 1992 to 2002. Univariate analyses were used to compare demographics, tumor characteristics, and surgical data; and logistic regression was used to determine independent predictors for recommendation/performance of surgery. Kaplan-Meier survival was assessed, and a Cox proportional hazards model was used to examine adjusted predictors of survival.
RESULTS: In total, 27,828 patients were identified; 81.4% were white, 11.5% were black, 7.2% were of other race. White patients and black patients presented with similar stage and had surgery recommended at similar rates (34.5% vs 34%, respectively; P = .57). Black patients underwent fewer resections (10.6% vs 12.7%; P < .001). Multivariate analysis confirmed that black patients were less likely to undergo resection (adjusted odds ratio, 0.69; 95% confidence interval [95% CI], 0.57-0.84). Overall, black patients had worse univariate survival. The survival among black patients who underwent resection did not differ statistically from the survival of similar white patients, although the median survival trended lower (11 months vs 13 months; P = .13). In a multivariate Cox model, black race predicted worse survival (hazards ratio, 1.11; 95% CI, 1.07-1.16), and pancreatic resection was protective (hazards ratio, 0.56; 95% CI, 0.53-0.59).
CONCLUSIONS: Black and white patients with pancreatic adenocarcinoma presented with similar stages and were recommended for pancreatectomy at similar rates, yet black patients underwent fewer resections. After resection, crude survival did not differ significantly between white and black patients, although multivariate analysis demonstrated a survival disadvantage for blacks despite adjusting for resection. The current results suggested that pancreatectomy may be underused for blacks. Maximizing resection rates for appropriate patients may be an important component in reducing outcome disparities for pancreatic adenocarcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19514091     DOI: 10.1002/cncr.24433

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  33 in total

1.  National disparities in minimally invasive surgery for pancreatic tumors.

Authors:  Emmanuel Gabriel; Pragatheeshwar Thirunavukarasu; Kristopher Attwood; Steven J Nurkin
Journal:  Surg Endosc       Date:  2016-07-13       Impact factor: 4.584

2.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.

Authors:  Vinamrata Singal; Ashwani K Singal; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-15       Impact factor: 4.553

3.  Racial disparities in operative outcomes after major cancer surgery in the United States.

Authors:  Shyam Sukumar; Praful Ravi; Akshay Sood; Mai-Kim Gervais; Jim C Hu; Simon P Kim; Mani Menon; Florian Roghmann; Jesse D Sammon; Maxine Sun; Vincent Q Trinh; Quoc-Dien Trinh
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

4.  Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.

Authors:  Lindsey Enewold; Linda C Harlan; Thomas Tucker; Shaun McKenzie
Journal:  J Gastrointest Cancer       Date:  2015-03

5.  Trends in racial disparities in pancreatic cancer surgery.

Authors:  Anand Shah; K S Clifford Chao; Truls Ostbye; Anthony W Castleberry; Ricardo Pietrobon; Beat Gloor; Bryan M Clary; Rebekah R White; Mathias Worni
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

6.  Time to Surgery: a Misguided Quality Metric in Early Stage Pancreatic Cancer.

Authors:  Katelin A Mirkin; Christopher S Hollenbeak; Joyce Wong
Journal:  J Gastrointest Surg       Date:  2018-03-08       Impact factor: 3.452

7.  Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.

Authors:  Taylor S Riall; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

Review 8.  Racial disparities in surgical care and outcomes in the United States: a comprehensive review of patient, provider, and systemic factors.

Authors:  Adil H Haider; Valerie K Scott; Karim A Rehman; Catherine Velopulos; Jessica M Bentley; Edward E Cornwell; Waddah Al-Refaie
Journal:  J Am Coll Surg       Date:  2013-01-11       Impact factor: 6.113

9.  Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma.

Authors:  George Molina; Thomas E Clancy; Thomas C Tsai; Miranda Lam; Jiping Wang
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

10.  Racial disparities in surgical resection and survival among elderly patients with poor prognosis cancer.

Authors:  Sha'Shonda L Revels; Mousumi Banerjee; Huiying Yin; Christopher J Sonnenday; John D Birkmeyer
Journal:  J Am Coll Surg       Date:  2012-11-27       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.